Health Condition 1: null- Renal Cell Carcinoma
Conditions
Interventions
None listed
Sponsors
Tata Memorial Hospital
Eligibility
Inclusion criteria
Inclusion criteria: All patients having undergone Nephron sparing surgery fro April 3, 2014 to July 24, 2016 will be enrolled retrospectively and patients treated with Nephron sparing surgery from 25th July 2016 onwards for five years and who sign the informed consent will be enrolled prospectively @ 40 patients per year.
Exclusion criteria
Exclusion criteria: All patients who do not consent for participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To study the pre-operative imaging characteristics of tumor and apply a score (RENAL, PADUA, C-INDEX). 2.To assess the surgical technique 3.To assess pathological characteristics of the excised tumor 4.To assess the correlation of nephrometry score with the surgical approach and intra-operative parameters Long term 1.To determine rate of local recurrence 2.To determine two and five year Disease Free Survival (DFS) and Overall Survival (OS) Timepoint: 1.To study the pre-operative imaging characteristics of tumor and apply a score (RENAL, PADUA, C-INDEX). 2.To assess the surgical technique 3.To assess pathological characteristics of the excised tumor immediate assessment. 4.To assess the correlation of nephrometry score with the surgical approach and intra-operative parameters Long term 1.To determine rate of local recurrence at 2 years 2.To determine Disease Free Survival (DFS) and Overall Survival (OS) two and five years. | — |
Secondary
| Measure | Time frame |
|---|---|
| To study the demographic characteristics and relevant 1. To study the pre-operative imaging characteristics of tumor and apply a score (RENAL, PADUA, C-INDEX). To assess the pathological characteristics of the excised tumor specimen â?? Timepoint: two, five and eight years | — |
Countries
India
Contacts
Public ContactDr Ganesh Bakshi
Tata Memorial Hospital
Outcome results
None listed